Correlation Between Akari Therapeutics and Armata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Armata Pharmaceuticals, you can compare the effects of market volatilities on Akari Therapeutics and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Armata Pharmaceuticals.
Diversification Opportunities for Akari Therapeutics and Armata Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Akari and Armata is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Armata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Armata Pharmaceuticals
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Armata Pharmaceuticals. In addition to that, Akari Therapeutics is 1.6 times more volatile than Armata Pharmaceuticals. It trades about -0.26 of its total potential returns per unit of risk. Armata Pharmaceuticals is currently generating about 0.04 per unit of volatility. If you would invest 232.00 in Armata Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 3.00 from holding Armata Pharmaceuticals or generate 1.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Armata Pharmaceuticals
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Armata Pharmaceuticals |
Akari Therapeutics and Armata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Armata Pharmaceuticals
The main advantage of trading using opposite Akari Therapeutics and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |